Jan 05 ,2025
Synopsis:
Asia equities poised to open mostly higher Monday. Futures in Japan traded lower, while Hong Kong and Australia were firmer. US contracts consolidated sharp cash session gains. Japan ADRs finished last week on a positive note, though follows a run of losses. Nasdaq Golden Dragon China index was up 0.93%. Tech leads were positive; Big Tech mostly higher, SOX index rallied 2.83%. Foxconn (2317.TT) posted stronger than expected Q4 revenues. Treasuries were weaker across the curve, ending off some early strength. Dollar index was down 0.4% after rallying to start the year. Gold finished down 0.5%. Bitcoin futures were up 1.1%, adding to Thursday's 4%+ rally. WTI crude settled up 1.1%.
Market sentiment improved somewhat on the back of Friday's gains, generally put down to dip-buying following five straight declines. Yet conviction remains subdued ahead of the return of usual market liquidity and upcoming risk events. Latest Fedspeak leaned hawkish with Daly and Kruger stressing inflation remains above target and more work needs to be done. This week's main event set to be US employment due Friday. Bloomberg consensus looks for headline non-farm payrolls to grow 160K in December following 227K in November with the unemployment rate steady at 4.2%. Markets looking further ahead to Trump's return to the White House on 20-Jan.
Main Asia theme remains China stimulus as markets await specifics on the size and content, as well as 2025 economic targets from the legislative sessions in March. Anxiety continues to simmer with economic indicators remaining patchy amid doubts there will be a major stimulus announcement after prior measures underwhelmed. South Korea political turmoil continues with impeached President Yoon waiting out the arrest warrant which expires at midnight Monday. However, market fallout has been largely limited beyond won volatility. Notable reverberations after US President Biden blocked Nippon Steel's (5401.JP) bid for US Steel (X) Friday citing national security. Nippon Steel said to be planning a legal suit against the US government.
Pre-open Company News:
6446.TT -- PharmaEssentia's Phase III clinical trial of P1101 for ET returns statistically significant topline results
AMATA.TB -- Amata Corp. Public initiated buy at Finansia Syrus
526299.IN -- Mphasis initiated buy at Jefferies
543066.IN -- SBI Cards & Payment Services upgraded to buy from reduce at Nomura
600580.CH -- Wolong Electric Group to terminate the listing application of Longneng Power at Beijing Stock Exchange
9928.HK -- Times Neighborhood Holdings CFO Kwok Pak Shing to resign effective 5-Jan; Wang Meng to be responsible for capital market functions of the Group effective 6-Jan
600383.CH -- Gemdale Corp. downgraded to sell from neutral at UBS
D05.SP -- DBS Group Holdings upgraded to buy from neutral at Citi
7113.MK -- Top Glove Corp. upgraded to neutral from sell at MIDF Investment Research
WLCON.PM -- Wilcon Depot downgraded to underperform from buy at BofA
500034.IN -- Bajaj Finance upgraded to buy from neutral at Nomura
3800.HK -- GCL Technology Holdings completes previously announced placing of 1.56B shares for net proceeds HK$1.53B
HFR.AU -- Highfield Resources to proceed with Yankuang transaction
S08.SP -- Singapore Post responds to media article regarding potential asset sales and capital return; has not entered into sale agreement for Famous Holdings
On Deck:
Japan:
Earnings:
Nextage (3186.JP), Hiday Hidaka (7611.JP), Daiseki (9793.JP), Arclands (9842.JP)
Thailand:
Economic:
07:00 SAST: CPI NSA Y/Y; consensus +1.3%
Market Data:
Gold (Feb 25): ($0.20) or (0.01%) to $2654.50
WTI Crude (Feb 25): +$0.28 or +0.38% to $74.24
$-¥: +0.16 or +0.10% to 157.4580
$-KRW: (1.00) or (0.07%) to 1466.2000
A$-$: +0.00 or +0.10% to 0.6220
$-INR: +0.00 or +0.00% to 85.7661
$-CNY: (0.00) or (0.01%) to 7.3196
If you would like to receive the Asian Market Preview daily, please search for Asia Pre-Market Updates in Alert Manager.
This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".
DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE